Atlas FDA

t:slim G4 Insulin Pump with Dexcom G4 Platinum CGM (t:slim G4 system); t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM

FDA premarket approval P140015/S024 · decided 2018-04-17

Approval details

PMA number
P140015
Supplement
S024
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
t:slim G4 Insulin Pump with Dexcom G4 Platinum CGM (t:slim G4 system); t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM
Generic name
Pump, infusion, insulin, to be used with invasive glucose sensor
Applicant
Tandem Diabetes Care, Inc.
Date received
2018-01-17
Decision date
2018-04-17
Days to decision
90 days
Decision code
APPR
Product code
OYC
Advisory committee
Clinical Chemistry
Expedited review
No
Location
San Diego, CA
Statement
Approval for minor design changes to the pump housing and patient line port of the t:slim X2 Insulin Pump. The t:slim X2 Insulin Pump is a part of the t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM System.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Control-IQ+ technology (K260429)Tandem Diabetes Care, Inc.2026-04-24
Tandem Mobi insulin pump with interoperable technology (K253074)Tandem Diabetes Care, Inc.2025-11-06
t:slim X2 insulin pump with interoperable technology (K250792)Tandem Diabetes Care, Inc.2025-09-24
Control-IQ+ technology (K250798)Tandem Diabetes Care, Inc.2025-05-21
Control-IQ+ technology (K243823)Tandem Diabetes Care, Inc.2025-02-24
Tandem Mobi Insulin Pump with interoperable technology (K241078)Tandem Diabetes Care, Inc.2024-07-26
Tandem Mobi insulin pump with interoperable technology (K240309)Tandem Diabetes Care, Inc.2024-03-21
t:slim X2 Insulin Pump with Interoperable Technology (K232380)Tandem Diabetes Care, Inc.2023-11-03